Copyright Reports & Markets. All rights reserved.

Global Irbesartan Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Buy now

Table of Contents

    1 Market Overview

    • 1.1 Irbesartan Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 Type I
      • 1.2.2 Type II
    • 1.3 Market Analysis by Applications
      • 1.3.1 Application I
      • 1.3.2 Application II
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2014-2024)
        • 1.4.1.2 Canada Market States and Outlook (2014-2024)
        • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2014-2024)
        • 1.4.2.2 France Market States and Outlook (2014-2024)
        • 1.4.2.3 UK Market States and Outlook (2014-2024)
        • 1.4.2.4 Russia Market States and Outlook (2014-2024)
        • 1.4.2.5 Italy Market States and Outlook (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2014-2024)
        • 1.4.3.2 Japan Market States and Outlook (2014-2024)
        • 1.4.3.3 Korea Market States and Outlook (2014-2024)
        • 1.4.3.4 India Market States and Outlook (2014-2024)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
        • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
        • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
        • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 Teva(TAPI)
      • 2.1.1 Business Overview
      • 2.1.2 Irbesartan Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Teva(TAPI) Irbesartan Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Taj Pharmaceuticals
      • 2.2.1 Business Overview
      • 2.2.2 Irbesartan Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Taj Pharmaceuticals Irbesartan Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Zhuhai Rundu Pharmaceutical
      • 2.3.1 Business Overview
      • 2.3.2 Irbesartan Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Zhuhai Rundu Pharmaceutical Irbesartan Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 HEC Group
      • 2.4.1 Business Overview
      • 2.4.2 Irbesartan Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 HEC Group Irbesartan Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Zhuhai Rundu Pharmaceutical
      • 2.5.1 Business Overview
      • 2.5.2 Irbesartan Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Zhuhai Rundu Pharmaceutical Irbesartan Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 ISHITA ACTIVE PHARMA INGREDIENTS (API)
      • 2.6.1 Business Overview
      • 2.6.2 Irbesartan Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 ISHITA ACTIVE PHARMA INGREDIENTS (API) Irbesartan Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Verdant Life Sciences
      • 2.7.1 Business Overview
      • 2.7.2 Irbesartan Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Verdant Life Sciences Irbesartan Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Irbesartan Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

    • 3.1 Global Irbesartan Sales and Market Share by Manufacturer (2017-2018)
    • 3.2 Global Irbesartan Revenue and Market Share by Manufacturer (2017-2018)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Irbesartan Manufacturer Market Share in 2018
      • 3.3.2 Top 6 Irbesartan Manufacturer Market Share in 2018
    • 3.4 Market Competition Trend

    4 Global Irbesartan Market Analysis by Regions

    • 4.1 Global Irbesartan Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Irbesartan Sales and Market Share by Regions (2014-2019)
      • 4.1.2 Global Irbesartan Revenue and Market Share by Regions (2014-2019)
    • 4.2 North America Irbesartan Sales and Growth Rate (2014-2019)
    • 4.3 Europe Irbesartan Sales and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Irbesartan Sales and Growth Rate (2014-2019)
    • 4.5 South America Irbesartan Sales and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Irbesartan Sales and Growth Rate (2014-2019)

    5 North America Irbesartan by Country

    • 5.1 North America Irbesartan Sales, Revenue and Market Share by Country
      • 5.1.1 North America Irbesartan Sales and Market Share by Country (2014-2019)
      • 5.1.2 North America Irbesartan Revenue and Market Share by Country (2014-2019)
    • 5.2 United States Irbesartan Sales and Growth Rate (2014-2019)
    • 5.3 Canada Irbesartan Sales and Growth Rate (2014-2019)
    • 5.4 Mexico Irbesartan Sales and Growth Rate (2014-2019)

    6 Europe Irbesartan by Country

    • 6.1 Europe Irbesartan Sales, Revenue and Market Share by Country
      • 6.1.1 Europe Irbesartan Sales and Market Share by Country (2014-2019)
      • 6.1.2 Europe Irbesartan Revenue and Market Share by Country (2014-2019)
    • 6.2 Germany Irbesartan Sales and Growth Rate (2014-2019)
    • 6.3 UK Irbesartan Sales and Growth Rate (2014-2019)
    • 6.4 France Irbesartan Sales and Growth Rate (2014-2019)
    • 6.5 Russia Irbesartan Sales and Growth Rate (2014-2019)
    • 6.6 Italy Irbesartan Sales and Growth Rate (2014-2019)

    7 Asia-Pacific Irbesartan by Country

    • 7.1 Asia-Pacific Irbesartan Sales, Revenue and Market Share by Country
      • 7.1.1 Asia-Pacific Irbesartan Sales and Market Share by Country (2014-2019)
      • 7.1.2 Asia-Pacific Irbesartan Revenue and Market Share by Country (2014-2019)
    • 7.2 China Irbesartan Sales and Growth Rate (2014-2019)
    • 7.3 Japan Irbesartan Sales and Growth Rate (2014-2019)
    • 7.4 Korea Irbesartan Sales and Growth Rate (2014-2019)
    • 7.5 India Irbesartan Sales and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Irbesartan Sales and Growth Rate (2014-2019)

    8 South America Irbesartan by Country

    • 8.1 South America Irbesartan Sales, Revenue and Market Share by Country
      • 8.1.1 South America Irbesartan Sales and Market Share by Country (2014-2019)
      • 8.1.2 South America Irbesartan Revenue and Market Share by Country (2014-2019)
    • 8.2 Brazil Irbesartan Sales and Growth Rate (2014-2019)
    • 8.3 Argentina Irbesartan Sales and Growth Rate (2014-2019)
    • 8.4 Colombia Irbesartan Sales and Growth Rate (2014-2019)

    9 Middle East and Africa Irbesartan by Countries

    • 9.1 Middle East and Africa Irbesartan Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East and Africa Irbesartan Sales and Market Share by Country (2014-2019)
      • 9.1.2 Middle East and Africa Irbesartan Revenue and Market Share by Country (2014-2019)
    • 9.2 Saudi Arabia Irbesartan Sales and Growth Rate (2014-2019)
    • 9.3 Turkey Irbesartan Sales and Growth Rate (2014-2019)
    • 9.4 Egypt Irbesartan Sales and Growth Rate (2014-2019)
    • 9.5 Nigeria Irbesartan Sales and Growth Rate (2014-2019)
    • 9.6 South Africa Irbesartan Sales and Growth Rate (2014-2019)

    10 Global Irbesartan Market Segment by Type

    • 10.1 Global Irbesartan Sales, Revenue and Market Share by Type (2014-2019)
      • 10.1.1 Global Irbesartan Sales and Market Share by Type (2014-2019)
      • 10.1.2 Global Irbesartan Revenue and Market Share by Type (2014-2019)
    • 10.2 Type I Sales Growth and Price
      • 10.2.1 Global Type I Sales Growth (2014-2019)
      • 10.2.2 Global Type I Price (2014-2019)
    • 10.3 Type II Sales Growth and Price
      • 10.3.1 Global Type II Sales Growth (2014-2019)
      • 10.3.2 Global Type II Price (2014-2019)

    11 Global Irbesartan Market Segment by Application

    • 11.1 Global Irbesartan Sales Market Share by Application (2014-2019)
    • 11.2 Application I Sales Growth (2014-2019)
    • 11.3 Application II Sales Growth (2014-2019)

    12 Irbesartan Market Forecast (2019-2024)

    • 12.1 Global Irbesartan Sales, Revenue and Growth Rate (2019-2024)
    • 12.2 Irbesartan Market Forecast by Regions (2019-2024)
      • 12.2.1 North America Irbesartan Market Forecast (2019-2024)
      • 12.2.2 Europe Irbesartan Market Forecast (2019-2024)
      • 12.2.3 Asia-Pacific Irbesartan Market Forecast (2019-2024)
      • 12.2.4 South America Irbesartan Market Forecast (2019-2024)
      • 12.2.5 Middle East and Africa Irbesartan Market Forecast (2019-2024)
    • 12.3 Irbesartan Market Forecast by Type (2019-2024)
      • 12.3.1 Global Irbesartan Sales Forecast by Type (2019-2024)
      • 12.3.2 Global Irbesartan Market Share Forecast by Type (2019-2024)
    • 12.4 Irbesartan Market Forecast by Application (2019-2024)
      • 12.4.1 Global Irbesartan Sales Forecast by Application (2019-2024)
      • 12.4.2 Global Irbesartan Market Share Forecast by Application (2019-2024)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Scope of the Report:
      The worldwide market for Irbesartan is expected to grow at a CAGR of roughly over the next five years, will reach million US$ in 2024, from million US$ in 2019, according to a new GIR (Global Info Research) study.
      This report focuses on the Irbesartan in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

      Market Segment by Manufacturers, this report covers
      Teva(TAPI) 
      Taj Pharmaceuticals
      Zhuhai Rundu Pharmaceutical
      HEC Group
      Zhuhai Rundu Pharmaceutical
      ISHITA ACTIVE PHARMA INGREDIENTS (API)
      Verdant Life Sciences

      Market Segment by Regions, regional analysis covers
      North America (United States, Canada and Mexico)
      Europe (Germany, France, UK, Russia and Italy)
      Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
      South America (Brazil, Argentina, Colombia etc.)
      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

      Market Segment by Type, covers
      Type I
      Type II

      Market Segment by Applications, can be divided into
      Application I
      Application II

      The content of the study subjects, includes a total of 15 chapters:
      Chapter 1, to describe Irbesartan product scope, market overview, market opportunities, market driving force and market risks.
      Chapter 2, to profile the top manufacturers of Irbesartan, with price, sales, revenue and global market share of Irbesartan in 2017 and 2018.
      Chapter 3, the Irbesartan competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
      Chapter 4, the Irbesartan breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
      Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
      Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
      Chapter 12, Irbesartan market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
      Chapter 13, 14 and 15, to describe Irbesartan sales channel, distributors, customers, research findings and conclusion, appendix and data source.

      Buy now